Author of the publication

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients

, , , , , , , , , , and . Clinical and translational radiation oncology, (2019)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Bandurska-Luque, Anna
add a person with the name Bandurska-Luque, Anna
 

Other publications of authors with the same name

Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis, , , , , , , , , and 1 other author(s). International Journal of Radiation Oncology* Biology* Physics, 92 (5): 1165--1174 (2015)NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy, , , , , , , , , and 1 other author(s). Acta Oncologica, 54 (9): 1658--1664 (2015)FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy, , , , , , , , , and 1 other author(s). Radiotherapy and Oncology, 122 (3): 437--444 (2017)Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients, , , , , , , , , and 1 other author(s). Clinical and translational radiation oncology, (2019)FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients, , , , , , , , , and 1 other author(s). Radiotherapy and Oncology, (2019)FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy, , , , , , , , , and 1 other author(s). Radiotherapy and Oncology, 122 (3): 437--444 (2017)NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy, , , , , , , , , and 1 other author(s). Acta Oncologica, 54 (9): 1658--1664 (2015)FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients, , , , , , , , , and 1 other author(s). Radiotherapy and Oncology, (2019)Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients, , , , , , , , , and 1 other author(s). Clinical and translational radiation oncology, (2019)